Etalon Diagnostics
Series A in 2022
Etalon Diagnostics is a biotechnology company focused on improving equine health and performance through a genetic diagnostic platform that provides panels of DNA tests for horses. It develops in-depth diagnostic panels to detect stress, disease, and biological age, and to identify genetic markers related to health, performance, and breeding. By integrating genetic profiling with data analytics and collaboration among horse owners, trainers, and veterinarians, the company offers diagnostics, ancestry insights, and breeding or sale packages designed to inform care, training, and lineage decisions. The business translates genetic discoveries into practical tools for the equine industry, aiming to advance welfare and athletic performance while providing clear, actionable genetic guidance for breeders and owners.
NextCapital
Series B in 2015
NextCapital, established in 1996, is a Chicago-based fintech company that partners with institutions to provide personalized financial planning and managed accounts to individual investors across various account types. Their digital advice platform, NextCapital, offers integrated services including account aggregation, analytics, planning, and portfolio management. This platform allows partners to customize advice methodology and fiduciary roles, serving a wide range of investors from beginners to high net worth individuals.
NextCapital
Series A in 2014
NextCapital, established in 1996, is a Chicago-based fintech company that partners with institutions to provide personalized financial planning and managed accounts to individual investors across various account types. Their digital advice platform, NextCapital, offers integrated services including account aggregation, analytics, planning, and portfolio management. This platform allows partners to customize advice methodology and fiduciary roles, serving a wide range of investors from beginners to high net worth individuals.
Pantheon Ventures
Acquisition in 2003
Pantheon Ventures (UK) LLP is a private equity firm founded in 1982 and based in London, with additional offices in North America, Asia, and South America. The firm specializes in direct investments and fund-of-funds across various asset classes, including private equity, infrastructure, and real assets. Pantheon targets a diverse range of investment opportunities, focusing on venture capital, buyouts, secondaries, and special situations, particularly in the United States, Europe, and Asia. It typically co-invests between $10 million and $50 million, and its investment strategies encompass early and late-stage venture capital, as well as distressed debt and restructuring. With approximately $24.1 billion in assets under management, Pantheon serves over 400 institutional investors, including pension plans and foundations. The firm employs a rigorous due diligence process and has built a robust network of relationships across its global markets, enabling it to effectively monitor its investments. Pantheon also structures customized separate account programs for high-net-worth individuals and institutional clients, with a focus on tailored investment solutions.